HAE

Clinical trials for HAE explained in plain language.

Never miss a new study

Get alerted when new HAE trials appear

Sign up with your email to follow new studies for HAE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1 Completed 1

New pill could stop debilitating HAE attacks in their tracks

Disease control Completed

This study tested an oral medication, BCX4161, to prevent sudden swelling attacks in people with hereditary angioedema (HAE), a rare genetic condition. About 110 adults with HAE type I or II took either a low dose, high dose, or placebo daily for 12 weeks. Researchers tracked how…

Matched conditions: HAE

Phase: PHASE2, PHASE3 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control

Last updated May 17, 2026 07:23 UTC

HAE

Get alerted when new HAE trials appear

New pill could stop debilitating HAE attacks in their tracks